Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer have?
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer has 812 citations in the OpenAlex counts ScholarIQ stores.
When was Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer published?
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer has 2011 year in the ScholarIQ index.
What is the open-access status of Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer?
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer has closed oa status in the ScholarIQ index.
What is the DOI of Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer?
The DOI for Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer is on the source record.
What is the PMID of Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer?
The PMID for Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer is on the source record.
What is the OpenAlex record for Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer?
The OpenAlex for Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer is on the source record.